Publications, Awards and Speaking Engagements
-
Patel, M.V., Davies, H., Williams, A.O., Bromilow, T., Baker, H., Mealing, S., Holmes, H., Anderson, N., Ahmed, O. Transarterial Therapies in Patients with Hepatocellular Carcinoma Eligible for Transarterial Embolization: A US Cost-Effectivemenss Analysis. Journal of Medical Economics. https://doi.org/10.1080/13696998.2023.2248840
Williams, A. O., Sridharan, N., Rojanasarot, S., Chaer, R., Anderson, N., Wifler, W., & Jaff, M. R. (2022). Population-Based Disparities in Inferior Vena Cava Filter Procedures Among Medicare Enrollees With Acute Venous Thromboembolism. Journal of the American College of Radiology : JACR, 19(6), 722–732. https://doi.org/10.1016/j.jacr.2022.03.011
Sridharan, N., Williams, A. O., Rojanasarot, S., Anderson, N., Wifler, W., Jaff, M. R., & Chaer, R. (2022). Cost Burden and Cost Influencers of Inferior Vena Cava Filter Placement and Retrieval among Medicare Beneficiaries with Acute Venous Thromboembolism. Journal of vascular and interventional radiology: JVIR, S1051-0443(22)01253-2. Advance online publication. https://doi.org/10.1016/j.jvir.2022.10.012
Patel, MV., Davies, H., Williams, AO., Bromilow, T., Baker, H., Mealing, S., Holmes, H., Anderson, N., Ahmed, S. Five-year cost effectiveness analysis of Y-90 glass microspheres and transarterial chemotherapies for the treatment of intermediate stage Hepatocellular carcinoma. Society for Interventional Oncology, Washington DC. January 19-23, 2023
Sterling, K. Williams, AO., Fu, S., Anderson, N., Jaff, MR., Grys, M., Wifler, W, Stern, L., Garg, K. (2022). In-Hospital Length of Stay for Treatment of Pulmonary Embolism: A Systematic Review and Model-Based-Network Meta-Analysis. International Symposium on Endovascular Therapy (ISET). Miami Beach, Florida. January 16-19, 2023
Garg, K., Fu, S., Anderson, N., Williams, AO., Jaff, MR., Grys, M., Stern, L., Wifler, W (2022). Does In-Hospital Mortality Vary Between Pulmonary Embolism Therapies? A Systematic Review and Model-based Meta-Analysis. American Venous Forum Annual Meeting. San Antonio, Texas. February 22-25, 2023
Fu, S., Anderson, N., Williams, AO., Jaff, MR., Grys, M., Wifler, W, Stern, L., Garg, K. (2022). Risk of Major Bleeding and Pulmonary Embolism Therapy: A Systematic Review and Model-Based Meta-Analysis. American Venous Forum Annual Meeting. San Antonio, Texas. February 22-25, 2023
Bromilow, T., Williams, AO., Davies, H., Anderson, N., Mealing, S., Kim, E. Cost- Effectiveness of Radioembolization with Y90 Glass Microspheres Versus Transarterial Chemotherapies in the Treatment of Intermediate Stage Hepatocellular Carcinoma: A US Hospital Perspective. Society for Interventional Radiology. Las Vegas, NV. October 16 - 18, 2022
Williams, A., Chaer, R., Sridharan, N., Rojanasarot, S., Anderson, N., & Wifler, W. (2022). POSB226 Variations in Inferior Vena Cava Filter Placement Among Medicare Beneficiaries with Acute Venous Thromboembolism. Value in Health, 25(1), S158
Sridharan, N., Williams, A., Chaer, R., Rojanasarot, S., Anderson, N., & Wifler, W. (2022). POSB124 Costs of Inferior Vena Cava Filter Placement for Medicare Beneficiaries with Acute Venous Thromboembolism. Value in Health, 25(1), S85.
Williams, A., Anderson, N., Gwon, Y. G., & Wifler, W. (2022). P32 Price Analysis of Cancer Therapies for the Treatment of Patients with Unresectable Hepatocellular Carcinoma. Value in Health, 25(1), S7
Sridharan, N., Williams, A., Rojanasarot, S., Chaer, R., Anderson, N., & Wifler, W. (2022). Costs and factors associated with inferior vena cava filter retrieval for Medicare beneficiaries with venous thromboembolism: A 7-year retrospective longitudinal study. Presented at the American Venous Forum Annual Meeting, Orlando, FL. February 23-28, 2022.
Sridharan, N., Williams, A., Rojanasarot, S., Chaer, R., Anderson, N., & Wifler, W. (2022). Real-world data analysis of inferior vena cava filter retrieval in Medicare patients with acute venous thromboembolism. American Venous Forum Annual Meeting, Orlando, FL. February 23-28, 2022.
“What Student Loans and Health Care Have in Common” - Mises Institute
“Economic Evaluation of Emerging Diagnostic Test for Coronary Artery Disease” - ISPOR 2017 Poster
Anderson, N. C. “Hem-Avert® Perianal Stabilizer for the Prevention of Cesarean Delivery: A Cost-Effectiveness Analysis.” Gynecology & Obstetrics 3 (2013): 1-6.
-
Guest lecturer Medical Devices Group; February 2023 (Reimbursement 201)
Guest lecturer at University of California San Francisco School of Medicine; November 2023
Panelist at Project Medtech Conference, Houston, TX; October 2023
Guest speaker, NYU Langone Dept of Interventional Radiology, NYC; September 2023
Guest lecturer Medical Devices Group; September 2023 (Inpatient billing)
Guest lecturer Medical Devices Group; July 2023
Guest lecturer at 10x Medical Device Conference, San Diego, CA; April 2023 (Artificial Intelligence in Healthcare)
Guest lecturer at 10x Medical Device Conference, San Diego, CA; April 2023 (Coding and Payment)
MVP in HEMA company-wide Boston Scientific; January 2023
Guest lecturer at University of California San Francisco School of Medicine; November 2022
Guest lecturer Medical Devices Group; September 2022
Panelist at Roche HeartFailure Advisory Board Meeting, Barcelona, Spain; August 2022
Guest speaker at Project Medtech, “Navigating the Complexities of the US Healthcare Reim. System”, Virtual; August 2022
Guest lecturer at 10x Medical Device Conference, San Diego, CA; May 2022
Guest lecturer at LogiMed Supply-Chain Conference, San Diego, CA; March 2022
Interviewed by Shannon Clark on the UserWise Podcast; January 2022
Guest lecturer at Hebrew University of Jerusalem - Biodesign Program, Jerusalem, Israel; December 2021
Guest speaker at BioHive Lifescience Conference, Salt Lake City, UT; November 2021
Guest lecturer at University of California San Francisco School of Medicine; November 2021
Guest lecturer Medical Devices Group; October 2021
Guest speaker at Medtech & Diagnostics Value & Access conference; September 2021
Guest lecturer Medical Devices Group; August 2021
Interviewed by Scott Nelson on the Medsider Podcast; July 2021
Guest lecturer Medical Devices Group; May 2021
Guest lecturer at University of California San Francisco School of Medicine; November 2020
Guest lecturer at Global Scale-up Program Europe; November 2020
Keynote speaker at Roche; (GoToMeeting); September 2020
Guest lecturer, Family Leadership Academy, Highland, UT; July 2020
Keynote speaker at Cambia Grove; (GoToMeeting); May 2020
Keynote speaker at BioIndustry Organization of Southern Arizona; Tucson, AZ; February 2020
Panelist at Roche Point of Care Advisory Board Meeting, New Orleans, LA; November 2019
Guest lecturer at University of California San Francisco School of Medicine; October 2019
Guest lecturer at 10x Medical Device Conference, San Diego, CA; May 2019
Guest lecturer at LogiMed Supply-Chain Conference, San Diego, CA; March 2019
Guest lecturer, Family Leadership Academy, Orem, UT; February 2019
Keynote speaker, SLC/Park City Angel Investor meeting, Salt Lake City, UT; December 2018
Guest lecturer at University of California San Francisco School of Medicine; November 2018
Guest lecturer at BioVentures University of Utah; September 2018
Guest lecturer at Society of Physician Entrepreneurs, Salt Lake City, UT; September 2018
Guest lecturer at University of Utah Department of Bioengineering BioInnovate Program; February 2018
Panelist at University of Utah Translational Medicine Symposium; February 2018
Guest lecturer at MedTech Monday, Costa Mesa, CA; January 2018
Guest lecturer at University of California San Francisco School of Medicine; November 2017
Panelist and guest lecturer at Ontario Biosciences Innovation Organization, Toronto, Canada; October 2017
Panelist at Roche Point of Care Advisory Board Meeting, Chicago, Il; September 2017
Guest lecturer at 10x Medical Device Conference, San Diego, CA; May 2017
Panelist at “Assessing Strategies to Improve the Market for Rapid Diagnostics for Bacterial Diseases”, Duke-Margolis Center for Health Policy, Washington DC; April 2017
Expert-in-Residence at Dubai 100 dHealth pre-accelerator, Dubai, U.A.E.; February 2017
Guest lecturer at University of Utah Department of Bioengineering BioInnovate Program; February 2017
Guest lecturer at MedBuild Idaho, Boise State University; November 2016
Guest lecturer at University of California San Francisco School of Medicine; October 2016
Guest lecturer at Collegium Aesculapium, Salt Lake City, UT; October 2016
Guest lecturer at Outsourcing in Clinical Trials Conference, Irvine, CA; July 2016
Guest lecturer at 10x Medical Device Conference, San Diego, CA; May 2016
Guest lecturer at University of Utah Department of Bioengineering BioInnovate Program; March 2016
Guest lecturer at Dubai 100 dHealth pre-accelerator, Dubai, U.A.E.; March 2016
Guest lecturer at Medical Device Marketing Summit, Tampa, FL; February 2016
Guest lecturer at University of California San Francisco School of Medicine; November 2015
Panelist at Healthbox/Church & State event on Medtech Commercialization Salt Lake City, UT; April 2015
Guest lecturer at University of Utah Department of Bioengineering BioInnovate Program; March 2015
Guest lecturer at Intermountain Healthcare Transformation Labs, Murray, UT; December 2014
Panelist and Moderator at World Stem Cell Summit, San Antonio, TX; December 2014
Guest lecturer at Healthbox, Salt Lake City, UT; November 2014
Guest lecturer at University of California San Francisco School of Medicine; November 2014
Panelist at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, San Diego, CA; October 2014
Panelist at Boise State University; June 2014
Guest lecturer at University of Utah Department of Bioengineering BioInnovate Program; March 2014
Panelist at University of Utah Translational Medicine Symposium; February 2014
Guest on the Peter Schiff Show; invited to speak on FDA decisions and reimbursement; February 2014
Guest lecturer at University of California, Office of Innovation (commercialization); November 2013
Guest lecturer at University of California San Francisco School of Medicine; November 2013
Guest lecturer at University of Utah Tech & Venture Commercialization Interchange Conference; October 2013
Guest lecturer at Stanford University Biodesign Program; August 2013
Guest on the Glenn Beck Program, presented a segment on Dept. of Education and biometric testing; April 2013
Guest lecturer at University of Utah School of Medicine; March 2013
Guest lecturer at University of Utah Department of Bioengineering BioInnovate Program; March 2013
Guest lecturer at University of California San Francisco School of Medicine; February 2013
Panelist at University of Utah Translational Medicine Symposium; February 2013
Guest lecturer at MD4s Tech Tuesday, Salt Lake City, UT; April 2012
Guest lecturer at University of Utah School of Medicine; March 2012
Panelist at University of Utah Translational Medicine Symposium; February 2012
First place in the Utah Entrepreneur Challenge for “Best Technology” out of 100 companies